Historique
Rapport
Pregnancy and opioid use: strategies for treatment
Auteur(s) :
OEDT = EMCDDA (Observatoire européen des drogues et des dépendances = European monitoring centre for drugs and drug addiction) ;
MINOZZI, S. ;
AMATO, L. ;
DAVOLI, M. ;
FERRI, M. ;
BO, A. ;
SIMON, R.
Année
2014
Page(s) :
34 p.
Sous-type de document :
Revue de la littérature / Literature review
Langue(s) :
Anglais
Collection :
EMCDDA Papers
ISBN :
978-92-9168-750-3
Domaine :
Drogues illicites / Illicit drugs
Organismes
OEDT
Thésaurus mots-clés
GROSSESSE
;
PRODUIT ILLICITE
;
OPIOIDES
;
TRAITEMENT
;
INTERVENTION
;
TRAITEMENT DE MAINTENANCE
;
THERAPIE COGNITIVO-COMPORTEMENTALE
;
METHODE
Résumé :
Illicit opioid consumption during pregnancy brings with it the risk of an increase in obstetric complications for the mother and a range of potential dangers for the child, both before and after birth. The primary goal when treating opioid dependence in pregnant women is to stabilise the patient and psychosocially assisted opioid substitution treatment is the preferred first-line therapy for this group.
Several combinations of substitution medicines and psychosocial approaches are available. This paper reviews methadone, buprenorphine and slow-release oral morphine, used in a range of combinations with cognitive behavioural approaches and contingency management in order to identify the strengths of each medicine and method.
Several combinations of substitution medicines and psychosocial approaches are available. This paper reviews methadone, buprenorphine and slow-release oral morphine, used in a range of combinations with cognitive behavioural approaches and contingency management in order to identify the strengths of each medicine and method.
Affiliation :
Cochrane Drugs and Alcohol Group ; EMCDDA